17-63964587-C-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PS1PM5PP3_ModeratePP5_Very_Strong
The NM_000334.4(SCN4A):c.1333G>C(p.Val445Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V445M) has been classified as Pathogenic.
Frequency
Consequence
NM_000334.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN4A | NM_000334.4 | c.1333G>C | p.Val445Leu | missense_variant | 9/24 | ENST00000435607.3 | NP_000325.4 | |
LOC105371858 | XR_001752969.2 | n.282C>G | non_coding_transcript_exon_variant | 4/5 | ||||
LOC105371858 | XR_001752970.2 | n.337C>G | non_coding_transcript_exon_variant | 4/5 | ||||
LOC105371858 | XR_934910.3 | n.157C>G | non_coding_transcript_exon_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN4A | ENST00000435607.3 | c.1333G>C | p.Val445Leu | missense_variant | 9/24 | 1 | NM_000334.4 | ENSP00000396320.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152246Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461388Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726978
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74382
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 18, 2023 | The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in multiple unrelated individuals with myotonia. At least one other missense variant at this codon is considered to be pathogenic or likely pathogenic, suggesting this variant may also cause disease. Computational tools predict that this variant is damaging. - |
Uncertain significance, flagged submission | clinical testing | Revvity Omics, Revvity | Sep 09, 2019 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 13, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25724373, 22653516, 9392583, 25839108, 33965302, 27199537, 34908252, 10218481) - |
Hyperkalemic periodic paralysis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 445 of the SCN4A protein (p.Val445Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant myotonia congenita (PMID: 27199537; Invitae). ClinVar contains an entry for this variant (Variation ID: 448262). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN4A protein function with a positive predictive value of 95%. This variant disrupts the p.Val445 amino acid residue in SCN4A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9392583, 22653516, 25724373, 25839108). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
SCN4A-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 15, 2023 | The SCN4A c.1333G>C variant is predicted to result in the amino acid substitution p.Val445Leu. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. An alternate G-to-A nucleotide change and a G-to-T nucleotide change at the same nucleotide position (c.1333) have been reported in individuals with autosomal dominant myotonia (c.1333G>A (p.Val445Met) and c.1333G>T (p.Val445Leu); Rosenfeld et al. 1997. PubMed ID: 9392583; Table 3, Sun et al. 2019. PubMed ID: 31567646; Table 2, Maggi et al. 2020. PubMed ID: 32849172; Table 4, Vereb. 2020. PubMed ID: 33263785; Table 3, Babić Božović et al. 2021. PubMed ID: 34106991; ClinVar Variation IDs: 5910 and 373945). The c.1333G>C (p.Val445Leu) variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at